RIGL vs. PAAS
RIGL (Rigel Pharmaceuticals, Inc.) and PAAS (Pan American Silver Corp.) are both stocks. RIGL operates in Biotechnology (Healthcare), while PAAS operates in Silver (Basic Materials). Over the past 10 years, RIGL returned 3.86%/yr vs 9.52%/yr for PAAS. Their 0.10 correlation means their historical movements had little consistent relationship.
Performance
RIGL vs. PAAS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RIGL achieves a -14.06% return, which is significantly higher than PAAS's -16.30% return. Over the past 10 years, RIGL has underperformed PAAS with an annualized return of 3.86%, while PAAS has yielded a comparatively higher 9.52% annualized return.
RIGL
- 1D
- -3.28%
- 1M
- -3.87%
- 6M
- 5.59%
- YTD
- -14.06%
- 1Y
- 74.79%
- 3Y*
- 40.40%
- 5Y*
- -1.65%
- 10Y*
- 3.86%
- ALL TIME*
- -10.60%
PAAS
- 1D
- -2.09%
- 1M
- -2.75%
- 6M
- -20.58%
- YTD
- -16.30%
- 1Y
- 61.72%
- 3Y*
- 40.98%
- 5Y*
- 11.18%
- 10Y*
- 9.52%
- ALL TIME*
- 8.09%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $152.76M | $168.96M | $235.64M | |
| $11.43M | $14.01M | $13.32M |
RIGL vs. PAAS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | -14.06% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
PAAS Pan American Silver Corp. | -16.30% | 160.40% | 26.61% | 2.50% | -33.00% | -26.78% | 46.88% | 63.86% | -5.30% | 3.86% |
Correlation
The correlation between RIGL and PAAS is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Nov 29, 2000 | 0.10 |
Fundamentals
RIGL:
$681.06M
PAAS:
$18.16B
RIGL:
$18.94
PAAS:
$3.12
RIGL:
1.94
PAAS:
13.80
RIGL:
0.00
PAAS:
0.08
RIGL:
2.36
PAAS:
4.37
RIGL:
1.81
PAAS:
2.47
RIGL:
$299.77M
PAAS:
$4.02B
RIGL:
$279.95M
PAAS:
$1.76B
RIGL:
$125.80M
PAAS:
$2.14B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RIGL vs. PAAS — Risk / Return Rank
RIGL
PAAS
RIGL vs. PAAS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and Pan American Silver Corp. (PAAS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RIGL | PAAS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.03 | ||
| Sortino ratioReturn per unit of downside risk | +0.32 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.21 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.50 | 1.60 | -0.10 |
| Martin ratioReturn relative to average drawdown | 2.51 | 3.51 | -0.99 |
Loading charts...
Drawdowns
RIGL vs. PAAS - Drawdown Comparison
The maximum RIGL drawdown since its inception was -99.37%, which is greater than PAAS's maximum drawdown of -85.10%. Use the drawdown chart below to compare losses from any high point for RIGL and PAAS.
Loading charts...
Drawdown Indicators
| RIGL | PAAS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -85.10% | -14.27% |
Max Drawdown (1Y)Largest decline over 1 year | -50.08% | -38.84% | -11.24% |
Max Drawdown (3Y)Largest decline over 3 years | -50.76% | -38.84% | -11.92% |
Max Drawdown (5Y)Largest decline over 5 years | -83.85% | -57.39% | -26.46% |
Max Drawdown (10Y)Largest decline over 10 years | -86.40% | -66.74% | -19.66% |
Current DrawdownCurrent decline from peak | -96.55% | -36.88% | -59.67% |
Average DrawdownAverage peak-to-trough decline | -90.93% | -41.61% | -49.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.86% | 17.65% | +12.21% |
Volatility
RIGL vs. PAAS - Volatility Comparison
Rigel Pharmaceuticals, Inc. (RIGL) and Pan American Silver Corp. (PAAS) have volatilities of 11.97% and 12.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RIGL | PAAS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.97% | 12.10% | -0.13% |
Volatility (6M)Calculated over the trailing 6-month period | 34.77% | 43.93% | -9.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 70.02% | 56.24% | +13.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.52% | 48.23% | +37.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 82.76% | 49.55% | +33.21% |
Dividends
RIGL vs. PAAS - Dividend Comparison
RIGL has not paid dividends to shareholders, while PAAS's dividend yield for the trailing twelve months is around 1.44%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAAS Pan American Silver Corp. | 1.44% | 0.89% | 1.98% | 2.45% | 2.75% | 1.36% | 0.64% | 0.59% | 0.96% | 0.64% | 0.33% | 4.23% |
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RIGL vs. PAAS - Financials Comparison
This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and Pan American Silver Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RIGL vs. PAAS - Profitability Comparison
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
PAAS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Pan American Silver Corp. reported a gross profit of 608.00M and revenue of 1.15B. Therefore, the gross margin over that period was 52.7%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
PAAS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Pan American Silver Corp. reported an operating income of 560.00M and revenue of 1.15B, resulting in an operating margin of 48.5%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
PAAS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Pan American Silver Corp. reported a net income of 457.00M and revenue of 1.15B, resulting in a net margin of 39.6%.
Frequently Asked Questions
RIGL and PAAS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PAAS has higher volatility (12.10%) compared to RIGL (11.97%). In terms of maximum drawdown, RIGL dropped -99.37% vs PAAS's -85.10%.
PAAS currently has the higher Sharpe Ratio (1.10 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RIGL and PAAS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer